Kabir Nath

Chief Executive Officer

London, England, United Kingdom

Professional Overview
Kabir Nath is an experienced pharmaceutical industry executive with a proven track record of driving growth and innovation. As the Chief Executive Officer of Compass Pathways, he leverages his deep expertise in global pharmaceuticals and executive leadership to guide the company's strategic direction and advancement of novel therapies.

Experience Summary

Current Role
As the Chief Executive Officer of Compass Pathways since August 2022, Kabir is responsible for overseeing the company's overall operations, financial performance, and the development of its innovative mental health treatments. Under his leadership, Compass Pathways is pioneering the use of psilocybin therapy to address unmet needs in mental healthcare, with a focus on transforming the lives of patients worldwide.

Career Progression
Prior to joining Compass Pathways, Kabir held several senior leadership positions within the pharmaceutical industry, including Senior Managing Director of the Global Pharmaceutical Business at Otsuka Pharmaceutical Co., Ltd., President and CEO of Otsuka North America Pharmaceuticals, and various roles of increasing responsibility at Bristol-Myers Squibb. Throughout his career, Kabir has demonstrated a strong ability to drive strategic growth, commercialize successful products, and foster collaborative partnerships that advance the industry's capabilities.

Academic Background
Kabir holds a relevant educational background, although specific details are not provided in the given information.

Areas of Expertise
Kabir's areas of expertise span global pharmaceutical operations, strategic leadership, commercial excellence, and innovative drug development. He has a deep understanding of the industry's evolving landscape and a proven ability to navigate complex regulatory environments and competitive markets.

Professional Impact
During his tenure at Otsuka Pharmaceutical and Bristol-Myers Squibb, Kabir played a pivotal role in the successful commercialization and expansion of several key pharmaceutical products, contributing to the companies' growth and improved patient outcomes. His industry expertise and visionary approach have positioned him as a respected leader within the pharmaceutical sector.

Conclusion
Kabir Nath's extensive experience in the pharmaceutical industry, combined with his strategic vision and commitment to innovation, make him well-suited to drive Compass Pathways' mission of transforming mental healthcare through the development of groundbreaking psilocybin-based therapies. As the Chief Executive Officer, he is poised to lead the company's continued growth and impact on the lives of patients worldwide.